Table 2 Frequency of intestinal parasites among the different regimens used with renal transplant recipients
From: Enteroparasitosis infections among renal transplant recipients in Khartoum state, Sudan 2012–2013
Treatment | E. H/D | E. C | C. P | G. L | E. V | H. N | A. L | S. S | Total |
|---|---|---|---|---|---|---|---|---|---|
Cyclosporine with Cortisone | 3 (27.3%) | 5 (45.5%) | 0 (0.0%) | 2 (18.2%) | 0 (0.0%) | 0 (0.0%) | 1 (9.1%) | 0 (0.0%) | 11 (17.2%) |
Cyclosporine with Azathioprine | 11 (39.3%) | 5 (17.9%) | 3 (10.7%) | 6 (21.4%) | 1 (3.6%) | 1 (3.6%) | 0 (0.0%) | 1 (3.6%) | 28 (43.8%) |
Tacrolimus combined with Mycophenolate mofetil | 8 (44.4%) | 10 (55.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 18 (28.1%) |
Cyclosporine combined with Cortisone and Mycophenolate mofetil | 2 (28.6%) | 1 (14.3%) | 2 (28.6%) | 1 (14.3%) | 0 (0.0%) | 0 (0.0%) | 1 (14.3%) | 0 (0.0%) | 7 (10.9%) |
Total | 24 (37.5%) | 21 (32.8%) | 5 (7.8%) | 9 (14.0%) | 1 (1.6%) | 1 (1.6%) | 2 (3.1%) | 1 (1.6%) | 64 (100%) |